外科理论与实践 ›› 2022, Vol. 27 ›› Issue (02): 100-106.doi: 10.16139/j.1007-9610.2022.02.003
收稿日期:
2022-01-20
出版日期:
2022-05-25
发布日期:
2022-06-16
通讯作者:
汤朝晖
E-mail:tzh1236@163.com
基金资助:
LIU Shenyang, TANG Zhaohui(), QUAN Zhiwei
Received:
2022-01-20
Online:
2022-05-25
Published:
2022-06-16
Contact:
TANG Zhaohui
E-mail:tzh1236@163.com
中图分类号:
刘深洋, 汤朝晖, 全志伟. 肝内胆管癌外科治疗进展[J]. 外科理论与实践, 2022, 27(02): 100-106.
LIU Shenyang, TANG Zhaohui, QUAN Zhiwei. Advances in surgical treatment of intrahepatic cholangiocarcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 100-106.
[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
doi: 10.3322/caac.21660 URL |
[2] | 童焕军, 于小鹏, 汤朝晖. 从病因学角度看肝内胆管癌的异质性[J]. 肝胆胰外科杂志, 2021, 33(11):641-646. |
[3] |
Hwang S, Lee YJ, Song GW, et al. Prognostic impact of tumor growth type on 7th AJCC staging system for intrahepatic cholangiocarcinoma: a single-center experience of 659 cases[J]. J Gastrointest Surg, 2015, 19(7):1291-1304.
doi: 10.1007/s11605-015-2803-6 pmid: 25820487 |
[4] |
Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival[J]. World J Surg, 2019, 43(7):1777-1787.
doi: 10.1007/s00268-019-04966-4 URL |
[5] |
Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer[J]. Lancet, 2021, 397(10272):428-444.
doi: 10.1016/S0140-6736(21)00153-7 pmid: 33516341 |
[6] |
Moris D, Tsilimigras DI, Kostakis LD, et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. EJSO, 2018, 44(7):927-938.
doi: 10.1016/j.ejso.2018.04.018 URL |
[7] |
Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, et al. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review[J]. J Gastrointest Surg, 2017, 21(6):1076-1085.
doi: 10.1007/s11605-017-3397-y URL |
[8] |
Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(6):1841-1850.
doi: 10.1245/s10434-019-07260-8 URL |
[9] |
Zhang XF, Bagante F, Chakedis J, et al. Perioperative and long-term outcome for intrahepatic cholangiocarcinoma: impact of major versus minor hepatectomy[J]. J Gastrointest Surg, 2017, 21(11):1841-1850.
doi: 10.1007/s11605-017-3499-6 URL |
[10] |
Li MX, Bi XY, Li ZY, et al. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. J Surg Res, 2016, 203(1):163-173.
doi: 10.1016/j.jss.2016.02.012 URL |
[11] |
Zhu H, Wang L, Wang M, et al. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma[J]. Am J Surg, 2021, 222(2):383-389.
doi: 10.1016/j.amjsurg.2020.12.022 URL |
[12] |
Murakami S, Ajiki T, Okazaki T, et al. Factors affecting survival after resection of intrahepatic cholangiocarcinoma[J]. Surg Today, 2014, 44(10):1847-1854.
doi: 10.1007/s00595-013-0825-9 pmid: 24452507 |
[13] | van Vugt JLA, Gaspersz MP, Coelen RJS, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma[J]. HPB(Oxford), 2018, 20(1):83-92. |
[14] | Reames B, Pawlik TM, Ejaz A, et al. Impact of major vascular resection on short- and long-term outcomes in patients with intrahepatic cholangiocarcinoma[J]. J Clin Oncol, 2017, 35(4_suppl):275. |
[15] |
Reames BN, Ejaz A, Koerkamp BG, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis[J]. J Surg Oncol, 2017, 116(2):133-139.
doi: 10.1002/jso.24633 URL |
[16] | Navarro JG, Lee JH, Kang I, et al. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?[J]. HPB(Oxford), 2020, 22(10):1411-1419. |
[17] |
Chang ME, Lei HJ, Chen MH, et al. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center[J]. J Chin Med Assoc, 2017, 80(3):140-146.
doi: 10.1016/j.jcma.2016.09.010 URL |
[18] |
Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahe-patic cholangiocarcinoma? a review of 17 years of expe-rience in a tertiary institution[J]. Surgery, 2015, 157(4):666-675.
doi: 10.1016/j.surg.2014.11.006 URL |
[19] | Zhou R, Lu D, Li W, et al. Is lymph node dissection ne-cessary for resectable intrahepatic cholangiocarcinoma? a systematic review and meta-analysis[J]. HPB(Oxford), 2019, 21(7):784-792. |
[20] |
Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study[J]. Surgery, 2019, 166(6):975-982.
doi: 10.1016/j.surg.2019.06.025 URL |
[21] |
Kim SH, Han DH, Choi GH, et al. Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma: a propensity score-matched study[J]. J Gastrointest Surg, 2019, 23(3):538-544.
doi: 10.1007/s11605-018-3899-2 URL |
[22] |
Tamandl D, Kaczirek K, Gruenberger B, et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma[J]. Br J Surg, 2009, 96(8):919-925.
doi: 10.1002/bjs.6654 pmid: 19591163 |
[23] |
Sweigert PJ, Eguia E, Janjua H, et al. Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?[J]. Surg Open Science, 2020, 2(3):107-112.
doi: 10.1016/j.sopen.2020.04.003 URL |
[24] |
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(11):1917-1928.
doi: 10.1007/s11605-013-2331-1 pmid: 24048613 |
[25] |
Benson AB 3rd, D'Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017[J]. J Natl Compr Canc Netw, 2017, 15(5):563-573.
doi: 10.6004/jnccn.2017.0059 URL |
[26] | Okami J, Dono K, Sakon M, et al. Patterns of regional lymph node involvement in intrahepatic cholanglocarcinoma of the left lobe[J]. J Gastrointeat Surg, 2003, 7(7):850-856. |
[27] |
Barth MJ. NCCN clinical practice guidelines in oncology (NCCN Guidelines)[J]. J Natl Compr Canc Netw, 2020, 18(11):1105.
doi: 10.6004/jnccn.2020.0036 URL |
[28] | Zhang XF, Xue F, Dong DH, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis[J]. Ann Surg, 2021, 274(6):E1187-E1195. |
[29] | Xiong Y, Jingdong L, Zhaohui T, et al. A consensus meeting on expert recommendations on operating specifications for laparoscopic radical resection of hilar cholangiocarcinoma[J]. Front Surg, 2021, 8:731448. |
[30] |
Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: Resectability, recurrence pattern, and outcomes[J]. J Am Coll Surg, 2001, 193(4):384-391.
doi: 10.1016/S1072-7515(01)01016-X URL |
[31] |
Franken LC, Coelen RJS, Roos E, et al. Staging Laparoscopy in patients with intrahepatic cholangiocarcinoma: is it still useful?[J]. Visceral Medicine, 2020, 36(6):501-505.
doi: 10.1159/000506297 pmid: 33442552 |
[32] |
Swaid F, Sucandy I, Tohme S, et al. Changes in performance of more than 1000 minimally invasive liver resections[J]. JAMA Surg, 2020, 155(10):986-988.
doi: 10.1001/jamasurg.2020.2623 URL |
[33] |
Ciria R, Cherqui D, Geller DA, et al. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing[J]. Ann Surg, 2016, 263(4):761-777.
doi: 10.1097/SLA.0000000000001413 URL |
[34] |
Wu J, Han J, Zhang Y, et al. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma[J]. Biosci Trends, 2020, 14(5):376-383.
doi: 10.5582/bst.2020.03293 URL |
[35] |
Haber PK, Wabitsch S, Kaestner A, et al. Laparoscopic liver resection for intrahepatic cholangiocarcinoma: a single-center experience[J]. J Laparoendosc Adv Surg Tech A, 2020, 30(12):1354-1359.
doi: 10.1089/lap.2020.0215 URL |
[36] |
Shiraiwa DK, Carvalho PFDC, Maeda CT, et al. The role of minimally invasive hepatectomy for hilar and intrahe-patic cholangiocarcinoma: a systematic review of the lite-rature[J]. J Surg Oncol, 2020, 121(5):863-872.
doi: 10.1002/jso.25821 pmid: 31902142 |
[37] |
Wei F, Wang G, Din J, et al. Is it time to consider laparoscopic hepatectomy for intrahepatic cholangiocarcinoma? a meta-analysis[J]. J Gastrointest Surg, 2020, 24(10):2244-2250.
doi: 10.1007/s11605-019-04404-9 URL |
[38] |
Ziogas IA, Giannis D, Esagian SM, et al. Laparoscopic versus robotic major hepatectomy: a systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(2):524-535.
doi: 10.1007/s00464-020-08008-2 URL |
[39] |
Qiu J, Chen S, Du C. A systematic review of robotic-assisted liver resection and meta-analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms[J]. Surg Endosc, 2016, 30(3):862-875.
doi: 10.1007/s00464-015-4306-7 URL |
[40] | Di Benedetto F, Magistri P. First case of full robotic ALPPS for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2021, 28(2):865. |
[41] | Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices[J]. J Vasc Interv Radiol, 2010, 21(8):S179-S186. |
[42] |
Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver[J]. Cardiovasc Intervent Radiol, 2013, 36(2):505-511.
doi: 10.1007/s00270-012-0405-1 pmid: 22572764 |
[43] |
Rubinsky B, Lee CY, Bastacky J, et al. The process of freezing and the mechanism of damage during hepatic cryosurgery[J]. Cryobiology, 1990, 27(1):85-97.
pmid: 2311412 |
[44] |
Savic LJ, Chapiro J, Hamm B, et al. Irreversible electroporation in interventional oncology: where we stand and where we go[J]. Rofo, 2016, 188(8):735-745.
doi: 10.1055/s-0042-104203 pmid: 27074423 |
[45] |
Kim GH, Kim PH, Kim JH, et al. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systema-tic review and meta-analysis[J]. Eur Radiol, 2021, 32(2):1205-1215.
doi: 10.1007/s00330-021-08216-x URL |
[46] |
Chu HH, Kim JH, Shin YM, et al. Percutaneous radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection: multivariable analysis of factors predicting survival outcomes[J]. Am J Roentgenol, 2021, 217(2):426-432.
doi: 10.2214/AJR.20.23461 URL |
[47] |
Sapisochin G, Rodriguez de Lope C, Gastaca M, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation[J]. Ann Surg, 2014, 259(5):944-952.
doi: 10.1097/SLA.0000000000000494 pmid: 24441817 |
[48] |
Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. “Very early” intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?[J]. Am J Transplant, 2014, 14(3):660-667.
doi: 10.1111/ajt.12591 pmid: 24410861 |
[1] | 孙跃明, 张冬生. 右半结肠癌CME/D3根治术淋巴结清扫内侧界的争议[J]. 外科理论与实践, 2023, 28(03): 202-207. |
[2] | 徐凯, 李百文. 早期胃癌及胃癌前病变的内镜黏膜下剥离术治疗[J]. 内科理论与实践, 2023, 18(02): 102-106. |
[3] | 颜海波, 夏中平, 陈善, 姜琳, 韩春. 甲状腺乳头状癌Delphian淋巴结转移的危险因素[J]. 外科理论与实践, 2022, 27(05): 453-457. |
[4] | 张吉祥, 谢智华, 综述, 李炜, 姜小清, 审校. 肝内胆管癌的分型和外科治疗热点[J]. 外科理论与实践, 2022, 27(05): 478-482. |
[5] | 周文斌, 唐新宇, 王水. 局部微波消融技术在乳腺癌治疗中的应用[J]. 外科理论与实践, 2022, 27(05): 403-405. |
[6] | 冯秋实. 胆总管结石的微创治疗[J]. 外科理论与实践, 2022, 27(03): 185-188. |
[7] | 陈胜. 三镜联合微创治疗胆囊结石合并胆总管结石的方案选择[J]. 外科理论与实践, 2022, 27(03): 198-202. |
[8] | 尹彦江, 罗治文, 陈晓, 张业繁, 黄振, 赵宏, 赵建军, 李智宇, 周健国, 蔡建强, 毕新宇. 肝内胆管癌病人肝脏手术切缘与预后的关系[J]. 外科理论与实践, 2022, 27(03): 221-228. |
[9] | 方诚, 夏勇, 王葵, 沈锋. 肝内胆管癌转化治疗现状与展望[J]. 外科理论与实践, 2022, 27(02): 107-112. |
[10] | 孟心娴 崔春晓 濮哲铭 张艳 冯少清 苏薇洁 李华 喜雯婧 闵沛如 张铮 许恒 李科 章一新. 1 470 nm 裸光纤二极管激光器治疗病理性瘢痕的临床研究[J]. 组织工程与重建外科杂志, 2021, 17(6): 487-. |
[11] | 王甜甜, 谢秋萍, 王平. 机器人甲状腺手术的颈侧区淋巴结清扫[J]. 外科理论与实践, 2021, 26(06): 476-481. |
[12] | 侯筱飒, 杨振江. 前哨淋巴结阳性乳腺癌患者发生非前哨淋巴结转移的危险因素分析[J]. 诊断学理论与实践, 2021, 20(03): 284-289. |
[13] | 刘坤, 郭伟. 肝胆管结石的微创治疗严格要求原则与内镜治疗[J]. 外科理论与实践, 2021, 26(02): 111-114. |
[14] | 王冲, 程石. 肝内胆管癌——国内外专家共识及指南解读[J]. 外科理论与实践, 2021, 26(02): 124-129. |
[15] | 刘红枝, 林自国, 黄建龙, 周伟平, 程张军, 楼健颖, 郑树国, 毕新宇, 王剑明, 郭伟, 李富宇, 王坚, 郑亚民, 李敬东, 程石, 刘景丰, 曾永毅. 切缘宽度对单发肝内胆管癌预后影响的多中心研究[J]. 外科理论与实践, 2021, 26(02): 130-137. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||